2010
DOI: 10.1016/j.ymgme.2010.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Elevated neonatal 3-OH isovalerylcarnitine due to breast milk sources in maternal 3-MCC deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 13 publications
0
4
0
Order By: Relevance
“…These programs have revealed a remarkable degree of phenotypic heterogeneity among individuals with abnormal levels of diagnostic metabolites, many of whom never manifest any clinical symptoms. In some cases, clinically silent “disease” has been detected in the asymptomatic mothers of babies subjected to screening programs, apparently because small amounts of the mother’s metabolites are transferred to the unaffected baby through the placenta, breast milk or other routes (Eichhorst et al, 2010). In other cases, IEMs once thought to be highly penetrant and severe now appear to be clinically silent in most individuals (Alfardan et al, 2010).…”
Section: Genetic Variation In Human Metabolism and Its Impact On Healmentioning
confidence: 99%
“…These programs have revealed a remarkable degree of phenotypic heterogeneity among individuals with abnormal levels of diagnostic metabolites, many of whom never manifest any clinical symptoms. In some cases, clinically silent “disease” has been detected in the asymptomatic mothers of babies subjected to screening programs, apparently because small amounts of the mother’s metabolites are transferred to the unaffected baby through the placenta, breast milk or other routes (Eichhorst et al, 2010). In other cases, IEMs once thought to be highly penetrant and severe now appear to be clinically silent in most individuals (Alfardan et al, 2010).…”
Section: Genetic Variation In Human Metabolism and Its Impact On Healmentioning
confidence: 99%
“…Maternal 3-MCC deficiency may be found by screening for positive normal neonates who have abnormal C5-OH levels. Persistent elevation in C5-OH in the non 3-MCC deficiency neonate could result from placental transfer of C5-OH, C5-OH transfer via the breast milk, and additionally, due to inefficient clearance mechanisms for the metabolite, early in postnatal development2457). According to a national survey of extended newborn screening by LC-MS/MS in Taiwan, the overall incidence of inborn error metabolism was approximately 1 per 6,219.…”
Section: Discussionmentioning
confidence: 99%
“…In the event that the maternal and the formula-fed infant metabolite levels are both abnormal, the metabolic work up should be repeated in the infant after one month to verify after one month to verify that the infant's levels are normalizing due to clearance of prenatally transferred metabolites; and metabolic laboratory work up should be repeated again in the infant after weaning, because maternal metabolites may be transferred to the infant via breast milk3). One study revealed higher levels of C5-OH level on breast milk samples that was diluted five times with methanol prior to sample processing and quantification than blood reference range2).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation